| Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling G Fusaro, P Dasgupta, S Rastogi, B Joshi, S Chellappan Journal of Biological Chemistry 278 (48), 47853-47861, 2003 | 457 | 2003 |
| Nicotine induces cell proliferation, invasion and epithelial‐mesenchymal transition in a variety of human cancer cell lines P Dasgupta, W Rizwani, S Pillai, R Kinkade, M Kovacs, S Rastogi, ... International Journal of Cancer 124 (1), 36-45, 2009 | 440 | 2009 |
| Nicotine induces cell proliferation by β-arrestin–mediated activation of Src and Rb–Raf-1 pathways P Dasgupta, S Rastogi, S Pillai, D Ordonez-Ercan, M Morris, E Haura, ... The Journal of clinical investigation 116 (8), 2208-2217, 2006 | 377 | 2006 |
| Detection of aflatoxin M1 contamination in milk and infant milk products from Indian markets by ELISA S Rastogi, PD Dwivedi, SK Khanna, M Das Food control 15 (4), 287-290, 2004 | 326 | 2004 |
| Psychiatric adverse events during treatment with brodalumab: analysis of psoriasis clinical trials MG Lebwohl, KA Papp, LB Marangell, J Koo, A Blauvelt, M Gooderham, ... Journal of the American Academy of Dermatology 78 (1), 81-89. e5, 2018 | 179 | 2018 |
| Glut-1 antibodies induce growth arrest and apoptosis in human cancer cell lines S Rastogi, S Banerjee, S Chellappan, GR Simon Cancer letters 257 (2), 244-251, 2007 | 164 | 2007 |
| Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells AV Timoshenko, S Rastogi, PK Lala British journal of cancer 97 (8), 1090-1098, 2007 | 142 | 2007 |
| Prohibitin facilitates cellular senescence by recruiting specific corepressors to inhibit E2F target genes S Rastogi, B Joshi, P Dasgupta, M Morris, K Wright, S Chellappan Molecular and cellular biology 26 (11), 4161-4171, 2006 | 115 | 2006 |
| Camptothecin induces nuclear export of prohibitin preferentially in transformed cells through a CRM-1-dependent mechanism S Rastogi, B Joshi, G Fusaro, S Chellappan Journal of Biological Chemistry 281 (5), 2951-2959, 2006 | 107 | 2006 |
| TNF-α response of vascular endothelial and vascular smooth muscle cells involve differential utilization of ASK1 kinase and p73 S Rastogi, W Rizwani, B Joshi, S Kunigal, SP Chellappan Cell Death & Differentiation 19 (2), 274-283, 2012 | 95 | 2012 |
| Protective effect of Ocimum sanctum on 3-methylcholanthrene, 7, 12-dimethylbenz (a) anthracene and aflatoxin B1 induced skin tumorigenesis in mice S Rastogi, Y Shukla, BN Paul, DK Chowdhuri, SK Khanna, M Das Toxicology and applied pharmacology 224 (3), 228-240, 2007 | 91 | 2007 |
| Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate‐to‐severe plaque psoriasis: integrated analysis of the … KA Papp, KB Gordon, RG Langley, MG Lebwohl, AB Gottlieb, S Rastogi, ... British Journal of Dermatology 179 (2), 320-328, 2018 | 70 | 2018 |
| Differential regulation of human YY1 and caspase 7 promoters by prohibitin through E2F1 and p53 binding sites B Joshi, S Rastogi, M Morris, LM Carastro, C DeCook, E Seto, ... Biochemical Journal 401 (1), 155-166, 2007 | 65 | 2007 |
| Skin tumorigenic potential of aflatoxin B1 in mice S Rastogi, RKS Dogra, SK Khanna, M Das Food and Chemical Toxicology 44 (5), 670-677, 2006 | 59 | 2006 |
| Activation of a methylated promoter mediated by a sequence-specific DNA-binding protein, RFX MI Niesen, AR Osborne, H Yang, S Rastogi, S Chellappan, JQ Cheng, ... Journal of Biological Chemistry 280 (47), 38914-38922, 2005 | 56 | 2005 |
| Rapid onset of action in patients with moderate-to-severe psoriasis treated with brodalumab: a pooled analysis of data from two phase 3 randomized clinical trials (AMAGINE-2 … A Blauvelt, KA Papp, MG Lebwohl, LJ Green, S Hsu, V Bhatt, S Rastogi, ... Journal of the American Academy of Dermatology 77 (2), 372-374, 2017 | 54 | 2017 |
| Direct binding of apoptosis signal-regulating kinase 1 to retinoblastoma protein: novel links between apoptotic signaling and cell cycle machinery P Dasgupta, V Betts, S Rastogi, B Joshi, M Morris, B Brennan, ... Journal of Biological Chemistry 279 (37), 38762-38769, 2004 | 53 | 2004 |
| Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States JJ Wu, SR Feldman, S Rastogi, B Menges, M Lingohr-Smith, J Lin Journal of Dermatological Treatment 29 (8), 769-774, 2018 | 47 | 2018 |
| A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light … JSS Andreas Nikolis, Steven Bernstein, Brian Kinney, Nicolo Scuderi, Shipra ... Clinical, Cosmetic and Investigational Dermatology 9, 115-125, 2016 | 40 | 2016 |
| Efficacy and safety of brodalumab in patients with moderate-to-severe plaque psoriasis and skin of color: results from the pooled AMAGINE-2/-3 randomized trials A McMichael, SR Desai, A Qureshi, S Rastogi, AF Alexis American journal of clinical dermatology 20, 267-276, 2019 | 35 | 2019 |
Srikumar ChellappanSenior Member and Chair, Moffitt Cancer CenterEmail yang diverifikasi di moffitt.org